[ad_1]
Turning a great idea into a viable startup takes patience, persistence, and more than a little luck. But when an idea is developed in a lab — whether it’s AI, biotech, robotics, or any other deep-tech research project — things get complicated and expensive quickly.
So, how do you navigate the difficult transition from research project to commercialization? There’s a lot to address in that one question, which is why we’re excited to join SOSV and PAW, CTO General Partner at IndieBio, on stage at TechCrunch Early Stage on April 20 in Boston, Massachusetts.
It’s one thing to build a working prototype in a controlled lab setting. It’s another thing to go into production and have your creation work consistently in the real world – every time, every time. Technical considerations are only one aspect of commercializing a lab project, which Wu will address in a session called “How to Turn Research into Business.” This is why we believe she is an excellent choice to tackle this topic.
At both SOSV and IndieBio, Wu is responsible for portfolio management and technical oversight. She invests in high-risk solutions to problems (both governmental and corporate). SOSV’s portfolio companies include Sample Apex, New Age Meat, Perfect Day and ReNubble. Wu uses rigorous science and engineering to transform new technologies into solutions for national defense, humanity and the planet.
Prior to joining IndieBion, Wu served as Scientific Director of Telefónica’s Barcelona-based Lunar Photo Factory Alpha. Her previous work includes director of science at the US Office of Naval Research (Global) and technical advisor at the Defense Advanced Research Projects Agency (DARPA).
All TechCrunch Early Stage sessions include plenty of Q&A time to get answers directly from the speakers. You’ll walk away with a deeper and deeper understanding of the topics and skills necessary for startup success. Buy an early bird founder ticket now and save $200.
[ad_2]
Source link
